The European biotechnology market is projected to grow at a significant CAGR of 6.9% during the forecast period (2020-2026). Next-generation sequencing (NGS), also known as high-throughput sequencing, is the catch-all term that is used to describe a number of different modern sequencing technologies such as Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent: Proton / PGM sequencing, SOLiD sequencing and so on. These recent technologies allow us to sequence DNA and RNA much more quickly and cheaply than the previously used Sanger sequencing. Such technologies have therefore revolutionized the study of genomics and molecular biology. The advancements in NGS are driving the R&D programs across the region.
Browse the full report description European Biotechnology Market Size, Share & Trends Analysis Report by Type (Healthcare, Crop Production and Agriculture, Industrial, Natural Resources & Environment, and Others) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/european-biotechnology-market
The rising lifestyle-oriented diseases such as CVD, CHD, Cancer, infectious diseases and so on are creating demand for NGS for the R&D process. Technological advancements have led to the introduction of NGS platforms in cancer investigation. NGS allows massive parallel sequencing that affords maximal tumor genomic assessment. NGS approaches are different, and concern DNA and RNA analysis. In recent years, NGS technologies have played a vital role in understanding the altered genetic pathway involved in human cancer. The fact that NGS has a high likelihood of producing results of unknown significance that it has attracted the researchers to explore the cancer disease.
Market Coverage
|
Report Elements |
Details |
|
Study Period |
2019-2026 |
|
Base year |
2019 |
|
Forecast period |
2020-2026 |
|
Segments Covered |
By Type |
|
Countries Covered |
UK, Germany, France, Spain, Italy, RoE |
|
Key Companies Profiled |
Amgen Inc., Novo
Nordisk A/S, CSL Ltd., Bristol-Myers Squibb Co., AstraZeneca PLC, Merck &
Co., Inc., Johnson & Johnson Services Inc., and Pfizer Inc. |
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID
o Most affected region/segment
o Recommendations
European Biotechnology Market – Segmentation
By Type
European Biotechnology Market – Segmentation by Geography
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/european-biotechnology-market